Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

5

About Bascom Ventures

Bascom Ventures is a venture fund that serves as a way for Wisconsin alums to add venture capital to their portfolio.

Bascom Ventures Headquarter Location

Wisconsin,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Bascom Ventures News

Cultured Decadence Raises $1.6M in Pre-Seed Funding

May 4, 2021

Cultured Decadence , a Madison, Wis.-based cellular agriculture company, closed its $1.6M pre-seed financing. Backers included Bluestein Ventures, Joyance Partners, Revolution’s Rise of the Rest Seed Fund, gener8tor, GlassWall Syndicate, Bascom Ventures, and China-based Dao Foods. The company, which also received non-dilutive funding from the Wisconsin Economic Development Corporation administered by the Center for Technology Commercialization (CTC), will use the funds to expand its team and continue development of cell-cultured lobster meat prototypes in preparation for a commercial launch. Led by John Pattison, CEO, and Ian Johnson, CSO, Cultured Decadence makes sustainable seafood products that have a lower environmental impact and higher nutritional quality through the cells of shellfish without the shell or organs. The company’s technology can be applied broadly to the $160 billion market for seafood including lobster, crab, shrimp, and scallops. FinSMEs 04/05/2021

Bascom Ventures Investments

5 Investments

Bascom Ventures has made 5 investments. Their latest investment was in Strategikon Pharma as part of their Series A on April 4, 2021.

CBI Logo

Bascom Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/22/2021

Series A

Strategikon Pharma

Yes

1

4/9/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

2/1/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

4/25/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/4/2019

Series C - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/22/2021

4/9/2021

2/1/2021

4/25/2019

4/4/2019

Round

Series A

Seed VC

Series A - II

Series A

Series C - III

Company

Strategikon Pharma

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.